Signaling flux redistribution at toll-like receptor pathway junctions

Kumar Selvarajoo, Yasunari Takada, Jin Gohda, Mohamed Helmy, Shizuo Akira, Masaru Tomita, Masa Tsuchiya, Jun Ichiro Inoue, Koichi Matsuo

Research output: Contribution to journalArticle

34 Citations (Scopus)

Abstract

Various receptors on cell surface recognize specific extracellular molecules and trigger signal transduction altering gene expression in the nucleus, Gain or loss-of-function mutations of one molecule have shown to affect alternative signaling pathways with a poorly understood mechanism. In Toll-like receptor (TLR) 4 signaling, which branches into MyD88- and TRAM-dependent pathways upon lipopolysaccharide (LPS) stimulation, we investigated the gain or loss-of-function mutations of MyD88. We predict, using a computational model built on the perturbation-response approach and the law of mass conservation, that removal and addition of MyD88 in TLR4 activation, enhances and impairs, respectively, the alternative TRAM-dependent pathway through signaling flux redistribution (SFR) at pathway branches. To verify SFR, we treated MyD88-deficient macrophages with LPS and observed enhancement of TRAM-dependent pathway based on increased IRF3 phosphorylation and induction of Cxcl10 and lfit2. Furthermore, increasing the amount of MyD88 in cultured cells showed decreased TRAM binding to TLR4. Investigating another TLR4 pathway junction, from TRIF to TRAF6, RIP1 and TBK1, the removal of MyD88-dependent TRAF6 increased expression of TRAM-dependent Cxl10 and lfit2. Thus, we demonstrate that SFR is a novel mechanism for enhanced activation of alternative pathways when molecules at pathway junctions are removed. Our data suggest that SFR may enlighten hitherto unexplainable intracellular signaling alterations in genetic diseases where gain or loss-of-function mutations are observed.

Original languageEnglish
Article numbere3430
JournalPLoS One
Volume3
Issue number10
DOIs
Publication statusPublished - 2008 Oct 17

Fingerprint

Toll-Like Receptors
TNF Receptor-Associated Factor 6
Fluxes
lipopolysaccharides
Mutation
Lipopolysaccharides
Inborn Genetic Diseases
Toll-Like Receptor 4
Cell Surface Receptors
genetic disorders
cultured cells
signal transduction
Cultured Cells
Signal Transduction
phosphorylation
macrophages
Molecules
Macrophages
Phosphorylation
Gene Expression

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Signaling flux redistribution at toll-like receptor pathway junctions. / Selvarajoo, Kumar; Takada, Yasunari; Gohda, Jin; Helmy, Mohamed; Akira, Shizuo; Tomita, Masaru; Tsuchiya, Masa; Inoue, Jun Ichiro; Matsuo, Koichi.

In: PLoS One, Vol. 3, No. 10, e3430, 17.10.2008.

Research output: Contribution to journalArticle

Selvarajoo, K, Takada, Y, Gohda, J, Helmy, M, Akira, S, Tomita, M, Tsuchiya, M, Inoue, JI & Matsuo, K 2008, 'Signaling flux redistribution at toll-like receptor pathway junctions', PLoS One, vol. 3, no. 10, e3430. https://doi.org/10.1371/journal.pone.0003430
Selvarajoo, Kumar ; Takada, Yasunari ; Gohda, Jin ; Helmy, Mohamed ; Akira, Shizuo ; Tomita, Masaru ; Tsuchiya, Masa ; Inoue, Jun Ichiro ; Matsuo, Koichi. / Signaling flux redistribution at toll-like receptor pathway junctions. In: PLoS One. 2008 ; Vol. 3, No. 10.
@article{0ca7718933334341a5244819143bba13,
title = "Signaling flux redistribution at toll-like receptor pathway junctions",
abstract = "Various receptors on cell surface recognize specific extracellular molecules and trigger signal transduction altering gene expression in the nucleus, Gain or loss-of-function mutations of one molecule have shown to affect alternative signaling pathways with a poorly understood mechanism. In Toll-like receptor (TLR) 4 signaling, which branches into MyD88- and TRAM-dependent pathways upon lipopolysaccharide (LPS) stimulation, we investigated the gain or loss-of-function mutations of MyD88. We predict, using a computational model built on the perturbation-response approach and the law of mass conservation, that removal and addition of MyD88 in TLR4 activation, enhances and impairs, respectively, the alternative TRAM-dependent pathway through signaling flux redistribution (SFR) at pathway branches. To verify SFR, we treated MyD88-deficient macrophages with LPS and observed enhancement of TRAM-dependent pathway based on increased IRF3 phosphorylation and induction of Cxcl10 and lfit2. Furthermore, increasing the amount of MyD88 in cultured cells showed decreased TRAM binding to TLR4. Investigating another TLR4 pathway junction, from TRIF to TRAF6, RIP1 and TBK1, the removal of MyD88-dependent TRAF6 increased expression of TRAM-dependent Cxl10 and lfit2. Thus, we demonstrate that SFR is a novel mechanism for enhanced activation of alternative pathways when molecules at pathway junctions are removed. Our data suggest that SFR may enlighten hitherto unexplainable intracellular signaling alterations in genetic diseases where gain or loss-of-function mutations are observed.",
author = "Kumar Selvarajoo and Yasunari Takada and Jin Gohda and Mohamed Helmy and Shizuo Akira and Masaru Tomita and Masa Tsuchiya and Inoue, {Jun Ichiro} and Koichi Matsuo",
year = "2008",
month = "10",
day = "17",
doi = "10.1371/journal.pone.0003430",
language = "English",
volume = "3",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Signaling flux redistribution at toll-like receptor pathway junctions

AU - Selvarajoo, Kumar

AU - Takada, Yasunari

AU - Gohda, Jin

AU - Helmy, Mohamed

AU - Akira, Shizuo

AU - Tomita, Masaru

AU - Tsuchiya, Masa

AU - Inoue, Jun Ichiro

AU - Matsuo, Koichi

PY - 2008/10/17

Y1 - 2008/10/17

N2 - Various receptors on cell surface recognize specific extracellular molecules and trigger signal transduction altering gene expression in the nucleus, Gain or loss-of-function mutations of one molecule have shown to affect alternative signaling pathways with a poorly understood mechanism. In Toll-like receptor (TLR) 4 signaling, which branches into MyD88- and TRAM-dependent pathways upon lipopolysaccharide (LPS) stimulation, we investigated the gain or loss-of-function mutations of MyD88. We predict, using a computational model built on the perturbation-response approach and the law of mass conservation, that removal and addition of MyD88 in TLR4 activation, enhances and impairs, respectively, the alternative TRAM-dependent pathway through signaling flux redistribution (SFR) at pathway branches. To verify SFR, we treated MyD88-deficient macrophages with LPS and observed enhancement of TRAM-dependent pathway based on increased IRF3 phosphorylation and induction of Cxcl10 and lfit2. Furthermore, increasing the amount of MyD88 in cultured cells showed decreased TRAM binding to TLR4. Investigating another TLR4 pathway junction, from TRIF to TRAF6, RIP1 and TBK1, the removal of MyD88-dependent TRAF6 increased expression of TRAM-dependent Cxl10 and lfit2. Thus, we demonstrate that SFR is a novel mechanism for enhanced activation of alternative pathways when molecules at pathway junctions are removed. Our data suggest that SFR may enlighten hitherto unexplainable intracellular signaling alterations in genetic diseases where gain or loss-of-function mutations are observed.

AB - Various receptors on cell surface recognize specific extracellular molecules and trigger signal transduction altering gene expression in the nucleus, Gain or loss-of-function mutations of one molecule have shown to affect alternative signaling pathways with a poorly understood mechanism. In Toll-like receptor (TLR) 4 signaling, which branches into MyD88- and TRAM-dependent pathways upon lipopolysaccharide (LPS) stimulation, we investigated the gain or loss-of-function mutations of MyD88. We predict, using a computational model built on the perturbation-response approach and the law of mass conservation, that removal and addition of MyD88 in TLR4 activation, enhances and impairs, respectively, the alternative TRAM-dependent pathway through signaling flux redistribution (SFR) at pathway branches. To verify SFR, we treated MyD88-deficient macrophages with LPS and observed enhancement of TRAM-dependent pathway based on increased IRF3 phosphorylation and induction of Cxcl10 and lfit2. Furthermore, increasing the amount of MyD88 in cultured cells showed decreased TRAM binding to TLR4. Investigating another TLR4 pathway junction, from TRIF to TRAF6, RIP1 and TBK1, the removal of MyD88-dependent TRAF6 increased expression of TRAM-dependent Cxl10 and lfit2. Thus, we demonstrate that SFR is a novel mechanism for enhanced activation of alternative pathways when molecules at pathway junctions are removed. Our data suggest that SFR may enlighten hitherto unexplainable intracellular signaling alterations in genetic diseases where gain or loss-of-function mutations are observed.

UR - http://www.scopus.com/inward/record.url?scp=55349098506&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=55349098506&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0003430

DO - 10.1371/journal.pone.0003430

M3 - Article

C2 - 18927610

AN - SCOPUS:55349098506

VL - 3

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e3430

ER -